AU2001263090A1 - Tnf and ifn stimulated genes and uses therefor - Google Patents
Tnf and ifn stimulated genes and uses thereforInfo
- Publication number
- AU2001263090A1 AU2001263090A1 AU2001263090A AU6309001A AU2001263090A1 AU 2001263090 A1 AU2001263090 A1 AU 2001263090A1 AU 2001263090 A AU2001263090 A AU 2001263090A AU 6309001 A AU6309001 A AU 6309001A AU 2001263090 A1 AU2001263090 A1 AU 2001263090A1
- Authority
- AU
- Australia
- Prior art keywords
- tnf
- uses therefor
- stimulated genes
- ifn stimulated
- ifn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6866—Interferon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Epidemiology (AREA)
- General Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20362400P | 2000-05-12 | 2000-05-12 | |
| US60/203,624 | 2000-05-12 | ||
| PCT/US2001/015402 WO2001088180A2 (en) | 2000-05-12 | 2001-05-11 | Tnf and ifn stimulated genes and uses therefor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001263090A1 true AU2001263090A1 (en) | 2001-11-26 |
Family
ID=22754683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001263090A Abandoned AU2001263090A1 (en) | 2000-05-12 | 2001-05-11 | Tnf and ifn stimulated genes and uses therefor |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20020164299A1 (en) |
| EP (1) | EP1287156A2 (en) |
| AU (1) | AU2001263090A1 (en) |
| WO (1) | WO2001088180A2 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06504912A (en) * | 1991-01-14 | 1994-06-09 | ニューヨーク・ユニバーシティ | Cytokine-inducing protein TSG-6, DNA encoding the TSG-6 protein, and use of the TSG-6 protein |
| JPH06506195A (en) * | 1991-01-14 | 1994-07-14 | ニューヨーク ユニバシテイ | Cytokine-induced protein, TSG-14, DNA encoding therefor and uses thereof |
-
2001
- 2001-05-11 AU AU2001263090A patent/AU2001263090A1/en not_active Abandoned
- 2001-05-11 EP EP01937342A patent/EP1287156A2/en not_active Withdrawn
- 2001-05-11 US US09/854,432 patent/US20020164299A1/en not_active Abandoned
- 2001-05-11 WO PCT/US2001/015402 patent/WO2001088180A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001088180A3 (en) | 2002-12-05 |
| US20020164299A1 (en) | 2002-11-07 |
| WO2001088180A2 (en) | 2001-11-22 |
| EP1287156A2 (en) | 2003-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2342900A (en) | Novel interferon stimulated and repressed genes | |
| AU7338200A (en) | User interface display and method | |
| AU5091201A (en) | Vegf-modulated genes and methods employing them | |
| AU4943200A (en) | Modified cytokine | |
| AU1344400A (en) | Inflammation-associated genes | |
| AU2002329759A1 (en) | Methyltransferase genes and uses thereof | |
| AU2001245987A1 (en) | Compositions and methods for gene therapy | |
| AU2002252976A1 (en) | Hydrazones and their therapeutic use | |
| AU2088801A (en) | Metastasis genes and uses thereof | |
| AU3072500A (en) | Rhamnosyl-transferase gene and uses thereof | |
| AU2001292936A1 (en) | Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines | |
| AUPQ659800A0 (en) | Genetic sequences and uses therefor | |
| AU2001229439A1 (en) | Bioconjugates and uses thereof | |
| AU2001293074A1 (en) | Human liver cell line | |
| AU2001295185A1 (en) | Multiplexing-interleaving and demultiplexing-deinterleaving | |
| AU2003223878A1 (en) | Heating conductor and use thereof | |
| AU2002222557A1 (en) | Interferon therapeutic effect-potentiating agents | |
| AU2001268053A1 (en) | Human sparc-homologous (hsparc-h1) gene and methods and uses thereof | |
| AU2003263895A1 (en) | Contraceptive methods and formulations | |
| AU1894601A (en) | Novel gene and use thereof | |
| AU2001263090A1 (en) | Tnf and ifn stimulated genes and uses therefor | |
| AU2669201A (en) | Taccalonolides and their use | |
| AU5979300A (en) | Angiopoietin-6 and uses thereof | |
| GB0020952D0 (en) | Genes and proteins and their uses | |
| AU2001277519A1 (en) | Bio-probes and use thereof |